Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
- NCT04270409
- 2019-003139-47; U1111-1222-7068; CT1204; EFC15992
Trial sponsor
Sanofi Aventis
Scientific Title
A Phase 3 Randomized, Open Label, Multicenter Study of Isatuximab (SAR650984) in Combination With Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With High-risk Smoldering Multiple Myeloma